Emergence of E. coli sequence type ST131
Emergence of E. coli sequence type ST131
批准号:
8390429
负责人:
JAMES R JOHNSON
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2013-09-30
关键词:
AbdomenAccountingAffectAffinityAntimicrobial ResistanceCefotaximeCephalosporin ResistanceCephalosporinsCharacteristicsClinicalCollectionCountryCyclophosphamideDataDomestic FowlsElementsEscherichia coliEscherichia coli InfectionsExhibitsFoodFood SupplyFrequenciesFutureGenomicsGenotypeHealthHospitalsHouseholdHumanInfectionInterventionIntestinesLaboratoriesLungMedical centerMeningitisMulti-Drug ResistanceMusOutcomeOutpatientsPatientsPersonsPrevalenceReportingResistanceResistance profileRiskSepsisSeverity of illnessSourceSyndromeTestingUrinary tract infectionVeteransVirulenceVirulentantimicrobialbasebeefbeta-Lactamasedemographicsfluoroquinolone resistancefoodbornegenetic elementindexingmembermouse modelpublic health relevancetransmission process
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
A specific group of Escherichia coli, sequence type ST131 is a newly recognized, widely disseminated cause of multi-drug-resistant (MDR extraintestinal infections that appears to represent an important emerging health threat in urgent need of study. Therefore, we propose to test the following Hypotheses by accomplishing the following Specific Aims: 1. ST131 has emerged in the past ten years as the predominant FQ-R E. coli clonal group in the US, including among veterans. Aim 1. Assess the annual prevalence of ST131 in the US among FQ-R and FQ-S E. coli in the SENTRY and TRUST collections (1999-2009) and from VA medical centers nationwide (2009). 2. ST131 is more fit than other E. coli in the pathogenic and commensal niches, and is present in foods. 2.a. In humans, ST131 causes more severe infections, in less compromised hosts, than other E. coli. Aim 2.a. Compare clinical presentation (syndrome and severity), illness outcome, and host compromise status among veterans with ST131 vs. non-ST131 E. coli clinical isolates. 2.b. In mice, ST131 is more virulent (UTI, sepsis) than other E. coli, including classic ExPEC strains. Aim 2.b. Compare the virulence of ST131 isolates, non-ST131 clinical isolates, and classic ExPEC strains. 2.c. ST131 exhibits enhanced intestinal colonization and host-to-host transmission, vs. other E. coli Aim 2.c.1. In humans, assess the prevalence of intestinal co-colonization among household members of index patients with ST131 vs. non-ST131 FQ-R E. coli clinical isolates. Aim 2.c.2. In mice, compare ST131 with non-ST131 E. coli for establishment of intestinal colonization after direct challenge or indirect exposure. 2.d. ST131 is present in retail foods, consistent with foodborne transmission. Aim 2.d.1. Determine the prevalence of ST131 in diverse retail foods. Aim 2.d.2. Assess the similarity of food-source versus human-source ST131 isolates according to genomic background, virulence genotype, and resistance profile. 3. Specific host characteristics predict ST131 infection. Aim 3. Compare demographics and exposures among veterans with ST131 infection versus concurrent controls with non-ST131 E. coli infection. 4. ST131 is more receptive to CTX-M-15-encoding genetic elements than are other E. coli. Aim 4. Compare transfer frequencies for CTX-M-15 (vs. other ESBL)-encoding elements from ST131 (vs. non-ST131) donors to ST131 (vs. non-ST131) recipients.
期刊论文(39)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Preoperative urine cultures at a veterans affairs medical center.
退伍军人事务医疗中心的术前尿培养。
DOI:
10.1001/2013.jamainternmed.834
发表时间:
2013
期刊:
JAMA internal medicine
影响因子:
39
作者:
[Drekonja,DimitriM, Zarmbinski,Breanna, Johnson,JamesR]
通讯作者:
Johnson,JamesR
Activity of Eravacycline against Escherichia coli Clinical Isolates Collected from U.S. Veterans in 2011 in Relation to Coresistance Phenotype and Sequence Type 131 Genotype.
埃拉瓦环素对 2011 年从美国退伍军人收集的大肠杆菌临床分离株的活性与共存表型和序列类型 131 基因型相关。
DOI:
10.1128/aac.02403-15
发表时间:
2015
期刊:
Antimicrobial agents and chemotherapy
影响因子:
4.9
作者:
[Johnson,JamesR, Porter,StephenB, Johnston,BrianD, Thuras,Paul]
通讯作者:
Thuras,Paul
Genotypic and phenotypic characterization of Escherichia coli isolates from children with urinary tract infection and from healthy carriers.
从尿路感染儿童和健康携带者中分离出的大肠杆菌的基因型和表型特征。
DOI:
10.1097/inf.0b013e31828ba3f1
发表时间:
2013
期刊:
The Pediatric infectious disease journal
影响因子:
--
作者:
[Kudinha,Timothy, Johnson,JamesR, Andrew,ScottD, Kong,Fanrong, Anderson,Peter, Gilbert,GwendolynL]
通讯作者:
Gilbert,GwendolynL
DOI:
10.1128/jcm.00378-15
发表时间:
2015-07
期刊:
Journal of clinical microbiology
影响因子:
9.4
作者:
[Stoesser N, Sheppard AE, Moore CE, Golubchik T, Parry CM, Nget P, Saroeun M, Day NP, Giess A, Johnson JR, Peto TE, Crook DW, Walker AS, Modernizing Medical Microbiology Informatics Group]
通讯作者:
Modernizing Medical Microbiology Informatics Group
Variation in resistance traits, phylogenetic backgrounds, and virulence genotypes among Escherichia coli clinical isolates from adjacent hospital campuses serving distinct patient populations.
来自邻近医院园区为不同患者群体提供服务的大肠杆菌临床分离株的耐药性特征、系统发育背景和毒力基因型的变化。
DOI:
10.1128/aac.00048-15
发表时间:
2015
期刊:
Antimicrobial agents and chemotherapy
影响因子:
4.9
作者:
[Drawz,SarahM, Porter,Stephen, Kuskowski,MichaelA, Johnston,Brian, Clabots,Connie, Kline,Susan, Ferrieri,Patricia, Johnson,JamesR]
通讯作者:
Johnson,JamesR
共 11 条
E. coli ST131 and Intestinal Colonization
-
批准号:8904313
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:JAMES R JOHNSON
-
依托单位:
Gut reservoir of E. coli ST131
-
批准号:9892970
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:JAMES R JOHNSON
-
依托单位:
E. coli ST131 and Intestinal Colonization
-
批准号:8644347
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:JAMES R JOHNSON
-
依托单位:
Emergence of E. coli sequence type ST131
-
批准号:8195979
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:JAMES R JOHNSON
-
依托单位:
Emergence of E. coli sequence type ST131
-
批准号:7689060
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:JAMES R JOHNSON
-
依托单位:
Emergence of E. coli sequence type ST131
-
批准号:7783809
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:JAMES R JOHNSON
-
依托单位:
Prolonged Analgesia in Rodents
-
批准号:7329096
-
项目类别:
-
资助金额:$9.85万
-
财政年份:2007
-
负责人:JAMES R JOHNSON
-
依托单位:
Resistant E.coli in Humans and Poultry
-
批准号:6946917
-
项目类别:
-
资助金额:$26.53万
-
财政年份:2004
-
负责人:JAMES R JOHNSON
-
依托单位:
Resistant E. coli in Humans and Poultry
-
批准号:6909507
-
项目类别:
-
资助金额:$27.42万
-
财政年份:2004
-
负责人:JAMES R JOHNSON
-
依托单位:
Infectious Disease Training in Clinical Investigation
-
批准号:7694026
-
项目类别:
-
资助金额:$24.75万
-
财政年份:2003
-
负责人:JAMES R JOHNSON
-
依托单位:
Infectious Disease Training in Clinical Investigation
-
批准号:8319467
-
项目类别:
-
资助金额:$33.24万
-
财政年份:2003
-
负责人:JAMES R JOHNSON
-
依托单位:
Infectious Disease Training in Clinical Investigation
-
批准号:8101927
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2003
-
负责人:JAMES R JOHNSON
-
依托单位:
Infectious Disease Training in Clinical Investigation
-
批准号:8496665
-
项目类别:
-
资助金额:$33.77万
-
财政年份:2003
-
负责人:JAMES R JOHNSON
-
依托单位:
Infectious Disease Training in Clinical Investigation
-
批准号:7280831
-
项目类别:
-
资助金额:$29.92万
-
财政年份:2003
-
负责人:JAMES R JOHNSON
-
依托单位:
Infectious Disease Training in Clinical Investigation
-
批准号:8928283
-
项目类别:
-
资助金额:$32.75万
-
财政年份:2003
-
负责人:JAMES R JOHNSON
-
依托单位:
Infectious Disease Training in Clinical Investigation
-
批准号:7901398
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2003
-
负责人:JAMES R JOHNSON
-
依托单位:
LONG ACTING NALTREXONE BIODEGRADABLE INJECTABLE GEL
-
批准号:6405096
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2001
-
负责人:JAMES R JOHNSON
-
依托单位:
LONG ACTING NALMEFENE BIODEGRADABLE INJECTABLE GEL
-
批准号:6338084
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2001
-
负责人:JAMES R JOHNSON
-
依托单位:
VIRULENCE OF A LINEAGE OF UROPATHOGENIC ESCHERICHIA COLI
-
批准号:2406423
-
项目类别:
-
资助金额:$14.14万
-
财政年份:1993
-
负责人:JAMES R JOHNSON
-
依托单位:
PATHOGENESIS AND PREVENTION OF BACTERIAL CYSTITIS
-
批准号:2147170
-
项目类别:
-
资助金额:$10.55万
-
财政年份:1993
-
负责人:JAMES R JOHNSON
-
依托单位:
海外基金